Protective role of melatonin in ochratoxin a toxicity in rat heart and lung

Huseyin Okutan1, Gulsen Aydin, Nurten Ozcelik

  • 1Süleyman Demirel University, School of Medicine, Department of Cardiovascular Surgery, Isparta, Turkey. okutanh@yahoo.com

Insights

Ochratoxin A (OTA) causes significant heart and lung damage in rats. Melatonin (MEL) treatment demonstrated protective effects, reducing OTA-induced toxicity in these organs.

Area of Science:

  • Toxicology
  • Pathology
  • Pharmacology

Background:

  • Ochratoxin A (OTA) is a fungal mycotoxin known for its hepatonephrotoxic effects.
  • Melatonin (MEL) possesses antioxidant and free-radical scavenging properties.

Purpose of the Study:

  • To investigate the histopathological effects of OTA on rat heart and lung tissues.
  • To evaluate the potential ameliorating effects of MEL against OTA-induced cardiotoxicity and pulmonary toxicity.

Main Methods:

  • Rats were divided into three groups: control, OTA-treated, and OTA + MEL-treated.
  • Histopathological examination of heart and lung tissues was performed after 30 days of treatment.
  • Specific dosages: OTA (289 μg/kg/day), MEL (10 mg/kg/day).

Main Results:

  • OTA induced significant myocardial damage, including cytoplasmic vacuolization, myocyte necrosis, and vascular changes.
  • OTA exposure led to substantial lung damage, characterized by alveolar congestion, hyperplasia, inflammation, and architectural distortion.
  • MEL treatment significantly reduced most OTA-induced histopathological damage in both heart and lung tissues, though not to control levels.

Conclusions:

  • Ochratoxin A induces significant histopathological damage in rat cardiac and pulmonary tissues.
  • Melatonin exhibits a significant protective effect against OTA-induced cardiotoxicity and pulmonary toxicity.
  • Further research may explore MEL as a potential therapeutic agent against mycotoxin-induced organ damage.

Related Concept Videos